C82.5A
Diffuse follicle center lymphoma, in remission
Clinical Classification Guidelines
Medical Intelligence & Overview
Diffuse follicle center lymphoma (DFCL) is a type of non-Hodgkin lymphoma originating from B-cells within lymph nodes. When this condition is in remission, it indicates that signs and symptoms have significantly improved or disappeared following treatment. This guide aims to inform patients about DFCL in remission, including its causes, symptoms, diagnosis, and general treatment approaches to support understanding of this condition.
Causes & Symptoms
Clinical Causes: Genetic mutations affecting lymphocytes (B-cells) Chronic immune system stimulation Infections, sometimes associated with viral agents Environmental exposure to certain chemicals or toxins Age-related changes in the immune system
Key Symptoms: Painless swelling of lymph nodes in areas such as the neck, armpits, or groin Unexplained weight loss Persistent fatigue or weakness Fever without an apparent infection Night sweats Itching skin Recurrent infections due to immune system impact
Diagnostic & Treatment
Diagnosis Path: Physical examination focusing on lymph node enlargement Blood tests to assess overall health and immune function Imaging studies such as CT scans or PET scans to identify affected areas Lymph node biopsy to examine tissue microscopically and confirm lymphoma subtype Bone marrow biopsy to check for spread Immunophenotyping and genetic studies to classify lymphoma and guide treatment
Treatment Protocols: Chemotherapy regimens tailored for non-Hodgkin lymphomas Immunotherapy, such as monoclonal antibodies (e.g., rituximab) Targeted therapies tailored to specific genetic or molecular features Radiation therapy in localized cases Stem cell transplantation in relapsed or refractory cases Supportive care to manage side effects and maintain quality of life Close monitoring during remission to detect potential relapse early
Clinical Advice & FAQs
Billing Guidance
Is C82.5A a billable ICD-10 code?
Yes, C82.5A is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C82.5A?
Clinical documentation must specify the nature of Diffuse follicle center lymphoma, in remission and any associated comorbidities for accurate reporting.
Cite this Clinical Reference